Search

Your search keyword '"Neha Mehta-Shah"' showing total 6 results
Start Over Author "Neha Mehta-Shah" Journal hematological oncology
6 results on '"Neha Mehta-Shah"'

1. THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS

Author

S. Fang, Youn H. Kim, Neha Mehta-Shah, William Blouin, C. Maccaro, Steve Horwitz, Helen Hancock, A.J. Moskowitz, Theresa Davey, Sunyoung Ryu, Patricia L. Myskowski, Ariela Noy, Michael S. Khodadoust, Lorenzo Falchi, David J. Straus, Natasha Galasso, David C. Fisher, Ahmet Dogan, E. Cathcart, Eric D. Jacobsen, Anita Kumar, J. Schwieterman, Leslie Perez, Nivetha Ganesan, Esther Drill, and David M. Weinstock

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Hematology, General Medicine, medicine.disease, Duvelisib, Peripheral T-cell lymphoma, Romidepsin, chemistry.chemical_compound, chemistry, Internal medicine, Relapsed refractory, medicine, Transaminitis, business, medicine.drug
Published
2021
Full Text
View/download PDF

2. NIVOLUMAB PLUS BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EXTENDED FOLLOW‐UP FROM THE PHASE 2 CHECKMATE 436 STUDY

Author

Neha Mehta-Shah, Pauline Brice, Justin Kline, John Kuruvilla, Paul M. Barr, David Cunningham, Nathalie A. Johnson, Giuseppe Gritti, Armando Santoro, Michelle A. Fanale, P. L. Zinzani, A.J. Moskowitz, and Stephen Francis

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Checkmate, Hematology, General Medicine, Internal medicine, Relapsed refractory, medicine, Primary Mediastinal Large B-Cell Lymphoma, Nivolumab, Brentuximab vedotin, business, medicine.drug
Published
2021
Full Text
View/download PDF

3. MULTI-CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC-486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T-CELL LYMPHOMA

Author

L. Benderoff, John P. Leonard, Morton Coleman, K. Van Besien, Lubomir Sokol, Jia Ruan, Giorgio Inghirami, Peter Martin, Leandro Cerchietti, Neha Mehta-Shah, A.J. Moskowitz, Sarah C. Rutherford, and Amelyn Rodriguez

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Phases of clinical research, Hematology, General Medicine, CHOP, medicine.disease, Peripheral T-cell lymphoma, Oral Azacitidine, Internal medicine, Medicine, Initial treatment, Center (algebra and category theory), business
Published
2019
Full Text
View/download PDF

4. Duvelisib, an oral dual PI3K-δ,γ inhibitor, efficacy and safety in patients with relapsed or refractory (RR) peripheral T-cell lymphoma: rationale for the phase 2 PRIMO trial

Author

Pierluigi Porcu, David M. Weinstock, E. Jacobsen, Youn H. Kim, Michael S. Khodadoust, Francine M. Foss, Jonathan E. Brammer, Steve Horwitz, A.J. Moskowitz, Neha Mehta-Shah, M. Baglio, Hagop Youssoufian, and Stephanie Lustgarten

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Hematology, General Medicine, medicine.disease, Duvelisib, Peripheral T-cell lymphoma, chemistry.chemical_compound, Refractory, chemistry, Internal medicine, medicine, In patient, business, PI3K/AKT/mTOR pathway
Published
2019
Full Text
View/download PDF

5. NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE 2 CHECKMATE 436 STUDY

Author

Stephen Francis, John Kuruvilla, Paul M. Barr, Manish Sharma, Nathalie A. Johnson, P. L. Zinzani, Armando Santoro, Thomas Manley, A.J. Moskowitz, Pauline Brice, Giuseppe Gritti, Justin Kline, David Cunningham, and Neha Mehta-Shah

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Checkmate, Hematology, General Medicine, Internal medicine, Relapsed refractory, Medicine, Primary Mediastinal Large B-Cell Lymphoma, Nivolumab, business, Brentuximab vedotin, medicine.drug
Published
2019
Full Text
View/download PDF

6. PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II-IV PERIPHERAL T-CELL NON-HODGKIN LYMPHOMA: PHASE I RESULTS FROM THE T-CELL CONSORTIUM

Author

Yasuhiro Oki, Jasmine Zain, Matthew A. Lunning, Anne W. Beaven, Steve Horwitz, A.J. Moskowitz, Brad M. Haverkos, S. M. Ansell, Mary Jo Lechowicz, Neha Mehta-Shah, and Ranjana H. Advani

Subjects
Cancer Research, business.industry, T cell, Hematology, General Medicine, Stage ii, Peripheral, 03 medical and health sciences, 0302 clinical medicine, T-Cell Non-Hodgkin Lymphoma, Phase i ii, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Phase (matter), Cancer research, medicine, business, Initial therapy, 030215 immunology, Lenalidomide, medicine.drug
Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results